Retro Bio­sciences inks blood dis­or­der deal as Sam Alt­man-backed biotech seeks $1B in funds

A longevi­ty start­up called Retro Bio­sciences is work­ing on per­son­al­ized blood dis­or­der ther­a­pies thanks to a part­ner­ship with the Mur­doch Chil­dren’s Re­search In­sti­tute in Aus­tralia …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER